| ... | ... | ... | Active substance | Medicinal product name | Pharmaceutical form | Strength | ATC code | Max. price range (€ incl. VAT) | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Not available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) | Rituximabum Biosimilar medicine |
Blitzima | Concentrate for solution for infusion | 500 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II stac.) |
L01FA01 — ANTINEOPLASTIC AGENTS |
 skatīt informāciju par zālēm un iepakojumiem |
||
| Not available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) | Rituximabum Biosimilar medicine |
Blitzima | Concentrate for solution for infusion | 100 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II stac.) |
L01FA01 — ANTINEOPLASTIC AGENTS |
skatīt informāciju par zālēm un iepakojumiem |
||
| Not available (according to the information provided by wholesalers) | Prescription (Pr.) |
Next lowest cost medicine |
Rituximabum | MabThera | Concentrate for solution for infusion | 100 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.) Next lowest cost medicine |
L01FA01 — ANTINEOPLASTIC AGENTS | € 579.13 |
skatīt informāciju par zālēm un iepakojumiem |
| Is available (according to the information provided by wholesalers) | Prescription (Pr.) |
Next lowest cost medicine |
Rituximabum | MabThera | Concentrate for solution for infusion | 500 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.) Next lowest cost medicine |
L01FA01 — ANTINEOPLASTIC AGENTS | € 1444.09 |
skatīt informāciju par zālēm un iepakojumiem |
| Is available (according to the information provided by wholesalers) | Prescription (Pr.) |
Next lowest cost medicine |
Rituximabum | MabThera | Solution for injection | 1400 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.) Next lowest cost medicine |
L01FA01 — ANTINEOPLASTIC AGENTS | € 2094.43 |
skatīt informāciju par zālēm un iepakojumiem |
| Not available (according to the information provided by wholesalers) | Prescription (Pr.) | Rituximabum | MabThera | Solution for injection | 1600 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.) |
L01FA01 — ANTINEOPLASTIC AGENTS |
skatīt informāciju par zālēm un iepakojumiem |
||
| Is available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) |
Reimbursed medicines reference product |
Rituximabum Biosimilar medicine |
Rixathon | Concentrate for solution for infusion | 100 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.II stac.) Reimbursed medicines reference product |
L01FA01 — ANTINEOPLASTIC AGENTS | € 418.50 |
skatīt informāciju par zālēm un iepakojumiem |
| Not available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) | Rituximabum Biosimilar medicine |
Rixathon | Concentrate for solution for infusion | 100 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II stac.) |
L01FA01 — ANTINEOPLASTIC AGENTS |
skatīt informāciju par zālēm un iepakojumiem |
||
| Is available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) |
Reimbursed medicines reference product |
Rituximabum Biosimilar medicine |
Rixathon | Concentrate for solution for infusion | 500 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.II stac.) Reimbursed medicines reference product |
L01FA01 — ANTINEOPLASTIC AGENTS | € 1039.84 |
skatīt informāciju par zālēm un iepakojumiem |
| Not available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) | Rituximabum Biosimilar medicine |
Rixathon | Concentrate for solution for infusion | 500 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II stac.) |
L01FA01 — ANTINEOPLASTIC AGENTS |
skatīt informāciju par zālēm un iepakojumiem |
||
| Not available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) | Rituximabum Biosimilar medicine |
Riximyo | Concentrate for solution for infusion | 100 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II stac.) |
L01FA01 — ANTINEOPLASTIC AGENTS |
skatīt informāciju par zālēm un iepakojumiem |
||
| Not available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) | Rituximabum Biosimilar medicine |
Riximyo | Concentrate for solution for infusion | 100 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II stac.) |
L01FA01 — ANTINEOPLASTIC AGENTS |
skatīt informāciju par zālēm un iepakojumiem |
||
| Not available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) | Rituximabum Biosimilar medicine |
Riximyo | Concentrate for solution for infusion | 500 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II stac.) |
L01FA01 — ANTINEOPLASTIC AGENTS |
skatīt informāciju par zālēm un iepakojumiem |
||
| Not available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) | Rituximabum Biosimilar medicine |
Riximyo | Concentrate for solution for infusion | 500 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II stac.) |
L01FA01 — ANTINEOPLASTIC AGENTS |
skatīt informāciju par zālēm un iepakojumiem |
||
| Is available (according to the information provided by wholesalers) | Prescription (Pr.) | Rituximabum Biosimilar medicine |
Ruxience | Concentrate for solution for infusion | 100 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.) |
L01FA01 — ANTINEOPLASTIC AGENTS | € 383.76 |
skatīt informāciju par zālēm un iepakojumiem |
|
| Is available (according to the information provided by wholesalers) | Prescription (Pr.) | Rituximabum Biosimilar medicine |
Ruxience | Concentrate for solution for infusion | 500 mg |
Is available (according to the information provided by wholesalers) Prescription (Pr.) |
L01FA01 — ANTINEOPLASTIC AGENTS | € 1901.58 |
skatīt informāciju par zālēm un iepakojumiem |
|
| Not available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) | Rituximabum Biosimilar medicine |
Truxima | Concentrate for solution for infusion | 500 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II stac.) |
L01FA01 — ANTINEOPLASTIC AGENTS |
skatīt informāciju par zālēm un iepakojumiem |
||
| Not available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) | Rituximabum Biosimilar medicine |
Truxima | Concentrate for solution for infusion | 100 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II stac.) |
L01FA01 — ANTINEOPLASTIC AGENTS |
skatīt informāciju par zālēm un iepakojumiem |
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.
Download search results (18 medicines) – ZIP archive containing the list in CSV, JSON and XML format. View list's field descriptions.
